New Omega-3 pill could boost heart health better than standard fish oil

NCT ID NCT07394517

Not yet recruiting Disease control Sponsor: Fundación del Caribe para la Investigación Biomédica Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a new omega-3 supplement called Ruby-O, made from phospholipids, raises omega-3 levels in the blood more effectively than standard omega-3 supplements. About 105 adults with mixed dyslipidemia (abnormal blood fats) who are already on statin therapy will take one of three supplements daily for 24 weeks. The main goal is to measure changes in the Omega-3 Index, a marker of heart health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Phospholipid omega-3 supplement (Ruby-O) and conventional triglyceride omega-3 supplement
What this could lead to: If successful, this could show that a new form of omega-3 supplement raises omega-3 levels in the blood better than standard supplements, potentially improving heart health.
What could go wrong: This is an early-stage trial with only 105 participants, so results may not apply to everyone. The supplement may not significantly outperform the standard version, and individual results vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MIXED DYSLIPIDEMIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperlipidemia, familial combined, LPL related

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

MIXED DYSLIPIDEMIA

Contacts and locations

Locations

Fundación del Caribe para la Investigación Biomédica (Fundación BIOS)

Barranquilla, Atlántico, 080020, Colombia

More trials for these conditions

Other studies related to the condition(s) this trial covers.